Academisch Medisch Centrum
Hospitals & Physicians Clinics · 201-500 Employees
View Company Info for Free
Overview
Phone Number
+31 205987003Website
www.amc.nlRevenue
$99.7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
1
2
2
1
About Academisch Medisch Centrum
Academisch Medisch Centrum is a company that operates in the Medical & Surgical Hospitals industry. It employs 250to499 people and has 50Mto100M of revenue.Explore more
Academisch Medisch Centrum Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Academisch Medisch Centrum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Academisch Medisch Centrum recently announced quarterly report
Check if Academisch Medisch Centrum has recently received funding, and reach out quickly before it becomes old news!
Academisch Medisch Centrum, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Academisch Medisch Centrum
Website visits: Recent activity has been detected on your website
Check out if Academisch Medisch Centrum is spiking on competitors!
Product Launch: Get notified when Academisch Medisch Centrum launches new products
Funding: Get notified immidiatlly once Academisch Medisch Centrum has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Academisch Medisch Centrum had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Academisch Medisch Centrum as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Academisch Medisch Centrum is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Academisch Medisch Centrum is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Academisch Medisch Centrum.
Academisch Medisch Centrum Tech Stack
A closer look at the technologies used by Academisch Medisch Centrum
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Academisch Medisch Centrum News & Media
Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress
CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that on Friday, May 25, 2018, at the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Congress in Copenhagen, Denmark, the Company is supporting a symposium titled: "Epigenetics in CKD & CVD: A potential breakthrough therapy?” The symposium highlights the role of epigenetics and BET-inhibition in chronic kidney disease and cardiovascPositive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR
- Excellent safety and low target lesion revascularization (TLR) rates persist - DURHAM, N.C., May 23, 2018 /PRNewswire/ -- A 24-month update on the DESSOLVE III trial of the MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent) was presented this week at...Once-Daily, Oral SAVAYSA® (edoxaban) Met Primary Endpoint in Investigational Hokusai-VTE CANCER Study
BASKING RIDGE, N.J., Dec. 12, 2017 /PRNewswire/ -- Daiichi Sankyo, Inc., (hereafter, Daiichi Sankyo), today announced results from the Hokusai-VTE CANCER study evaluating oral edoxaban (known by the brand names SAVAYSA® in the U.S. and LIXIANA® outside the U.S.), and found that edoxaban...NorthSea Therapeutics Secures €25M in Series A Funding
NorthSea Therapeutics B.V., a Naarden, The Netherlands-based biotech company, completed a €25m Series A funding. The investment syndicate led by Forbion and BGV includes Novo Seeds, the early-stage investment arm of Novo Holdings A/S and New Science Ventures. From the investor synicate, the following representatives will join the board of NST: – Sander Slootweg (Chair, […]
Read more news
Top Hospitals & Physicians Clinics Companies
Frequently Asked Questions Regarding Academisch Medisch Centrum
Sign Up For FreeTo access detailed company insights
Academisch Medisch Centrum is a company that operates in the Medical & Surgical Hospitals industry. It employs 250to499 people and has 50Mto100M of revenue.... Read More
